Blood Pressure Response to Zofenopril or Irbesartan Each Combined with Hydrochlorothiazide in High-Risk Hypertensives Uncontrolled by Monotherapy: A Randomized, Double-Blind, Controlled, Parallel Group, Noninferiority Trial

In this randomized, double-blind, controlled, parallel group study (ZENITH), 434 essential hypertensives with additional cardiovascular risk factors, uncontrolled by a previous monotherapy, were treated for 18 weeks with zofenopril 30 or 60 mg plus hydrochlorothiazide (HCTZ) 12.5 mg or irbesartan 15...

Descripción completa

Detalles Bibliográficos
Autores principales: Malacco, Ettore, Omboni, Stefano, Parati, Gianfranco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540998/
https://www.ncbi.nlm.nih.gov/pubmed/26347187
http://dx.doi.org/10.1155/2015/139465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540998/
https://www.ncbi.nlm.nih.gov/pubmed/26347187
http://dx.doi.org/10.1155/2015/139465

Ejemplares similares